金吾财讯 | 诺华制药(NVS)股价走高,截止发稿,涨1.35%,报114.15美元。消息面上,公司一季度业绩显示,经调整后核心营业利润达55.8亿美元,同比增长27%,高于市场预期的50.7亿美元;核心每股收益增长31%至2.28美元。期内,营收132亿美元,高于分析师普遍预期的131.2亿美元。公司CEO表示,公司重点品牌包括Kisqali、Kesimpta和Leqvio继续展现强劲势头,预计...
Source Link金吾财讯 | 诺华制药(NVS)股价走高,截止发稿,涨1.35%,报114.15美元。消息面上,公司一季度业绩显示,经调整后核心营业利润达55.8亿美元,同比增长27%,高于市场预期的50.7亿美元;核心每股收益增长31%至2.28美元。期内,营收132亿美元,高于分析师普遍预期的131.2亿美元。公司CEO表示,公司重点品牌包括Kisqali、Kesimpta和Leqvio继续展现强劲势头,预计...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.